Fresh hope for breast cancer patients
The therapy offers hope to hundreds of Irish patients for whom other treatments have stopped working.
Lapatinib, developed by GlazoSmithKline (GSK), targets a specific type of breast cancer that accounts for more than a quarter of all breast cancer cases.